FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1563-1565 November 23, 2000 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kotani, N. PubMed Citation

Postherpetic neuralgia is the most frequent and feared complication of herpes zoster, which is the most common neurologic illness in the United States.¹ Data from the VZV (Varicella Zoster Virus) Research Foundation, in New York City, indicate that herpes zoster may occur in as many as 850,000 people in the United States each year. Postherpetic neuralgia, when defined as persistent pain occurring one month after the healing of the herpetic rash, affects about 10 percent of patients with herpes zoster. However, the incidence of postherpetic neuralgia is directly related to age. Up to 75 percent of people with herpes zoster . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Galer, B. S., Gammaitoni, A. R. (2003). More Than 7 Years of Consistent Neuropathic Pain Relief in Geriatric Patients. Arch Intern Med 163: 628-628 [Full Text]  
• Nelson, D. A., Landau, W. M., Lampe, J. B., Hindinger, C., Reichmann, H., Lewis, G., Niebergall, H., Priebe, H.-J., Zetlaoui, P. J., Cosserat, J., Srinivasan, B., Kotani, N., Matsuki, A., Watson, C. P. N. (2001). Intrathecal Methylprednisolone for Postherpetic Neuralgia. NEJM 344: 1019-1022 [Full Text]  
• (2001). A New Treatment for Postherpetic Neuralgia?. Journal Watch Dermatology 2001: 7-7 [Full Text]  
• (2000). Intrathecal Steroids for Postherpetic Neuralgia. JWatch General 2000: 4-4 [Full Text]